SMO ClinPlus CO.,LTD. (SHE:301257)

China flag China · Delayed Price · Currency is CNY
57.14
+0.78 (1.38%)
Apr 28, 2026, 4:00 PM EDT
102.05%
Market Cap 4.51B
Revenue (ttm) 842.50M
Net Income (ttm) 109.64M
Shares Out 79.00M
EPS (ttm) 1.38
PE Ratio 41.41
Forward PE n/a
Dividend 0.27 (0.48%)
Ex-Dividend Date Nov 28, 2025
Volume 1,985,390
Average Volume 2,319,914
Open 56.41
Previous Close 56.36
Day's Range 56.41 - 58.76
52-Week Range 26.23 - 85.00
Beta 1.22
RSI 47.21
Earnings Date Apr 29, 2026

About SMO ClinPlus CO.,LTD.

SMO ClinPlus CO.,LTD. provides site management services in research development in pharmaceuticals, medical devices, and health-related products in China. The company offers early modeling, preliminary preparation plan trial site initiation, on-site execution, and project management services. SMO ClinPlus CO.,LTD. was founded in 2009 and is based in Shanghai, China. [Read more]

Sector Healthcare
Founded 2009
Employees 4,271
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301257
Full Company Profile

Financial Performance

In 2025, SMO ClinPlus CO.,LTD.'s revenue was 842.50 million, an increase of 4.82% compared to the previous year's 803.73 million. Earnings were 109.64 million, an increase of 3.01%.

Financial Statements

News

There is no news available yet.